The history of genetics in inflammatory bowel disease

Annals of Gastroenterology

Volumn 27, Issue 4, 2014, Pages 294-303

  Ek, Weronica E ^a   D’Amato, Mauro ^a   Halfvarson, Jonas ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

Author keywords

Genetic epidemiology; Genetics; Inflammatory bowel disease

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ARTICLE; CROHN DISEASE; EPIDEMIOLOGICAL DATA; FAMILY STUDY; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC RISK; GENOME; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; INFLAMMATORY BOWEL DISEASE; MOLECULAR GENETICS; MYCOBACTERIOSIS; PATHOGENESIS; PREVALENCE; TWIN CONCORDANCE; ULCERATIVE COLITIS;

EID: 84922378529     PISSN: 11087471     EISSN: 17927463     Source Type: Journal    
DOI: None     Document Type: Article

References (106)

1. Economou M, Pappas G. New global map of Crohn’s disease: Genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis 2008;14:709-720.
2. Binder V. Genetic epidemiology in inflammatory bowel disease. Dig Dis 1998;16:351-355.
3. Kyle J. Crohn’s disease in the northeastern and northern Isles of Scotland: An epidemiological review. Gastroenterology 1992;103:392-399.
4. Lapidus A. Crohn’s disease in Stockholm County during 1990-2001: an epidemiological update. World J Gastroenterol 2006;12:75-81.
5. Gunesh S, Th omas GA, Williams GT, Roberts A, Hawthorne AB. The incidence of Crohn’s disease in Cardiff over the last 75 years: an update for 1996-2005. Aliment Pharmacol Ther 2008;27:211-219.
6. Chouraki V, Savoye G, Dauchet L, et al. The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10-to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther 2011;33:1133-1142.
7. Molinie F, Gower-Rousseau C, Yzet T, et al. Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988-1999). Gut 2004;53:843-848.
8. Sood A, Midha V, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003;52:1587-1590.
9. Yang SK, Hong WS, Min YI, et al. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol 2000;15:1037-1042.
10. Yao T, Matsui T, Hiwatashi N. Crohn’s disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000;43:S85-S93.
11. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflamatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 2008;14:542-549.
12. Sandler E. Epidemiology of inflammatory bowel disease. In: Targan SR, Shanahan F (editors): Inflammatory bowel disease: from bench to bedside. Williams & Wilkins: Baltimore; 1994, pp. 5-30.
13. Roth MP, Petersen GM, McElree C, Feldman E, Rotter JI. Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology 1989;97:900-904.
14. Yang H, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 1993;34:517-524.
15. Niv Y, Abuksis G, Fraser GM. Epidemiology of Crohn’s disease in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol 1999;94:2961-2965.
16. Odes HS, Fraser D, Hollander L. Epidemiological data of Crohn’s disease in Israel: etiological implications. Public Health Rev 1989;17:321-335.
17. Allchin WH. Ulcerative colitis. Proc Roy Soc Med 1909;2:59-75.
18. Kirsner JB, Spencer JA. Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis. Ann Intern Med 1963;59:133-144.
19. Halme L, Turunen U, Helio T, et al. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population. Scand J Gastroenterol 2002;37:692-698.
20. Monsen U, Brostrom O, Nordenvall B, Sorstad J, Hellers G. Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. Scand J Gastroenterol 1987;22:214-218.
21. Monsen U, Bernell O, Johansson C, Hellers G. Prevalence of inflammatory bowel disease among relatives of patients with Crohn’s disease. Scand J Gastroenterol 1991;26:302-306.
22. Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen IA, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991;324:84-88.
23. Mayberry JF, Rhodes J, Newcombe RG. Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn’s disease. Br Med J 1980;280:84.
24. Probert CS, Jayanthi V, Hughes AO, Th ompson JR, Wicks AC, Mayberry JF. Prevalence and family risk of ulcerative colitis and Crohn’s disease: an epidemiological study among Europeans and south Asians in Leicestershire. Gut 1993;34:1547-1551.
25. Satsangi J, Rosenberg WMC, Jewell DP. The prevalence of inflammatory bowel disease in relatives of patients with Crohn’s disease. Eur J Gastroenterol Hepatol 1994:5:413-416.
26. Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn’s disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996;111:597-603.
27. Weterman IT, Pena AS. Familial incidence of Crohn’s disease in The Netherlands and a review of the literature. Gastroenterology 1984;86:449-452.
28. Carbonnel F, Macaigne G, Beaugerie L, Gendre JP, Cosnes J. Crohn’s disease severity in familial and sporadic cases. Gut 1999;44:91-95.
29. Freeman HJ. Familial Crohn’s disease in single or multiple firstdegree relatives. J Clin Gastroenterol 2002;35:9-13.
30. Farmer RG, Michener WM, Mortimer EA. Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterol 1980;9:271-277.
31. Bayless TM, Tokayer AZ, Polito JM, II, Quaskey SA, Mellits ED, Harris ML. Crohn’s disease: concordance for site and clinical type in affected family members--potential hereditary influences. Gastroenterology 1996;111:573-579.
32. Roth MP, Petersen GM, McElree C, Vadheim CM, Panish JF, Rotter JI. Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology 1989;96:1016-1020.
33. Loft us EV, Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-1517.
34. Bridger S, Lee JC, Bjarnason I, Jones JE, Macpherson AJ. In siblings with similar genetic susceptibility for inflamatory bowel disease, smokers tend to develop Crohn’s disease and nonsmokers develop ulcerative colitis. Gut 2002;51:21-25.
35. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119-124.
36. Nimmo ER, Prendergast JG, Aldhous MC, et al. Genomewide methylation profi ling in Crohn’s disease identifies altered epigenetic regulation of key host defense mechanisms including the Th 17 pathway. Inflamm Bowel Dis 2012;18:889-899.
37. Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP. Review article: the genetics of inflammatory bowel disease. Aliment Pharmacol Ther 2001;15:731-748.
38. Bennett RA, Rubin PH, Present DH. Frequency of inflamatory bowel disease in off spring of couples both presenting with inflammatory bowel disease. Gastroenterology 1991;100:1638-1643.
39. Laharie D, Debeugny S, Peeters M, et al. Inflammatory bowel disease in spouses and their off spring. Gastroenterology 2001;120:816-819.
40. Lennard-Jones JE. Classifi cation of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2-6.discussion 16-19.
41. Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut 2006;55(Suppl 1):i1-i15.
42. Satsangi J, Grootscholten C, Holt H, Jewell DP. Clinical patterns of familial inflammatory bowel disease. Gut 1996;38:738-741.
43. Colombel JF, Grandbastien B, Gower-Rousseau C, et al. Clinical characteristics of Crohn’s disease in 72 families. Gastroenterology 1996;111:604-607.
44. Lee JC, Lennard-Jones JE. Inflammatory bowel disease in 67 families each with three or more affected first-degree relatives. Gastroenterology 1996;111:587-596.
45. Annese V, Andreoli A, Astegiano M, et al. Clinical features in familial cases of Crohn’s disease and ulcerative colitis in Italy: a GISC study. Italian Study Group for the Disease of Colon and Rectum. Am J Gastroenterol 2001;96:2939-2945.
46. Polito JM, II, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM. Crohn’s disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996;111:580-586.
47. Akolkar PN, Gulwani-Akolkar B, Heresbach D, et al. Differences in risk of Crohn’s disease in off spring of mothers and fathers with inflammatory bowel disease. Am J Gastroenterol 1997;92:2241-2244.
48. Zelinkova Z, Stokkers PC, van der Linde K, Kuipers EJ, Peppelenbosch MP, van der Woude CP. Maternal imprinting and female predominance in familial Crohn’s disease. J Crohns Colitis 2012;7:771-776.
49. Franchimont D, Belaiche J, Louis E, et al. Familial Crohn’s disease: a study of 18 families. Acta Gastroenterol Belg 1997;60:134-137.
50. Cottone M, Brignola C, Rosselli M, et al. Relationship between site of disease and familial occurrence in Crohn’s disease. Dig Dis Sci 1997;42:129-132.
51. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988;29:990-996.
52. Orholm M, Binder V, Sorensen TI, Rasmussen LP, Kyvik KO. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 2000;35:1075-1081.
53. Subhani J, Montgomery SM, Pounder RE, Wakefield AJ. Concordance rates of twins and siblings in inflammatory bowel disease (IBD). [abstract]. Gut 1998;42(Suppl I):A40.
54. Th ompson NP, Driscoll R, Pounder RE, Wakefield AJ. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 1996;312:95-96.
55. Spehlmann ME, Begun AZ, Burghardt J, Lepage P, Raedler A, Schreiber S. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis 2008;14:968-976.
56. Ng SC, Woodrow S, Patel N, Subhani J, Harbord M. Role of genetic and environmental factors in British twins with inflamatory bowel disease. Inflamm Bowel Dis 2012;18:725-736.
57. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a longterm follow-up of concordance and clinical characteristics. Gastroenterology 2003;124:1767-1773.
58. Halfvarson J. Genetics in twins with Crohn’s disease: less pronounced than previously believed? Inflamm Bowel Dis 2011;17:6-12.
59. Jess T, Riis L, Jespersgaard C, et al. Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease. Am J Gastroenterol 2005;100:2486-2492.
60. Brant SR. Update on the heritability of inflammatory bowel disease: the importance of twin studies. Inflamm Bowel Dis 2011;17:1-5.
61. Bengtson MB, Aamodt G, Vatn MH, Harris JR. Concordance for IBD among twins compared to ordinary siblings--a Norwegian population-based study. J Crohns Colitis 2010;4:312-318.
62. Gasche C, Scholmerich J, Brynskov J, et al. A simple classifi cation of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
63. Halfvarson J, Jess T, Bodin L, et al. Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease. Inflamm Bowel Dis 2007;13:1536-1544.
64. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science 2012;335:936-941.
65. Weinrieb IJ, Fineman RM, Spiro HM. Turner syndrome and inflammatory bowel disease. N Engl J Med 1976;294:1221-1222.
66. Schinella RA, Greco MA, Cobert BL, Denmark LW, Cox RP. Hermansky-Pudlak syndrome with granulomatous colitis. Ann Intern Med 1980;92:20-23.
67. Couper R, Kapelushnik J, Griffiths AM. Neutrophil dysfunction in glycogen storage disease Ib: association with Crohn’s-like colitis. Gastroenterology 1991;100:549-554.
68. Lloyd-Still JD. Crohn’s disease and cystic fi brosis. Dig Dis Sci 1994;39:880-885.
69. Compton RF, Sandborn WJ, Yang H, et al. A new syndrome of Crohn’s disease and pachydermoperiostosis in a family. Gastroenterology 1997;112:241-249.
70. Jayson MI, Bouchier IA. Ulcerative colitis in patients with ankylosing spondylitis. Proc R Soc Med 1968;61:340-341.
71. Yates VM, Watkinson G, Kelman A. Further evidence for an association between psoriasis, Crohn’s disease and ulcerative colitis. Br J Dermatol 1982;106:323-330.
72. Minuk GY, Lewkonia RM. Possible familial association of multiple sclerosis and inflammatory bowel disease. N Engl J Med 1986;314:586.
73. Cottone M, Cappello M, Puleo A, Cipolla C, Filippazzo MG. Familial association of Crohn’s and coeliac diseases. Lancet 1989;2:338.
74. Lees CW, Barrett JC, Parkes M, Satsangi J. New IBD genetics: common pathways with other diseases. Gut 2011;60:1739-1753.
75. Asakura H, Tsuchiya M, Aiso S, et al. Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis. Gastroenterology 1982;82:413-418.
76. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature 1996;379:821-823.
77. Satsangi J, Parkes M, Louis E, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996;14:199-202.
78. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-247.
79. Cooney R, Jewell D. The genetic basis of inflammatory bowel disease. Dig Dis 2009;27:428-442.
80. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001;411:599-603.
81. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001;411:603-606.
82. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003;124:521-536.
83. Riis L, Vind I, Vermeire S, et al. The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients. Inflamm Bowel Dis 2007;13:24-32.
84. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007;316:889-894.
85. Yamazaki K, McGovern D, Ragoussis J, et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn’s disease. Hum Mol Genet 2005;14:3499-3506.
86. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-1463.
87. Fisher SA, Tremelling M, Anderson CA, et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn’s disease. Nat Genet 2008;40:710-712.
88. Matsuda A, Suzuki Y, Honda G, et al. Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 2003;22:3307-3318.
89. Goyette P, Lefebvre C, Ng A, et al. Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol 2008;1:131-138.
90. Henderson P, van Limbergen JE, Wilson DC, Satsangi J, Russell RK. Genetics of childhood-onset inflammatory bowel disease. Inflamm Bowel Dis 2011;17:346-361.
91. Imielinski M, Baldassano RN, Griffiths A, et al. Common variants at five new loci associated wiThearly-onset inflammatory bowel disease. Nat Genet 2009;41:1335-1340.
92. Kugathasan S, Baldassano RN, Bradfield JP, et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflamatory bowel disease. Nat Genet 2008;40:1211-1215.
93. Amre DK, Mack DR, Morgan K, et al. Investigation of reported associations between the 20q13 and 21q22 loci and pediatriconset Crohn’s disease in Canadian children. Am J Gastroenterol 2009;104:2824-2828.
94. Franke A, McGovern DP, Barrett JC, et al. Genome-wide metaanalysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet 2010;42:1118-1125.
95. Anderson CA, Boucher G, Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011;43:246-252.
96. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008;453:1051-1057.
97. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005;129:827-836.
98. Cohen R, Robinson D, Jr., Paramore C, Fraeman K, Renahan K, Bala M. Autoimmune disease concomitance among inflamatory bowel disease patients in the United States, 2001-2002. Inflamm Bowel Dis 2008;14:738-743.
99. Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization. Am J Gastroenterol 2007;102:1429-1435.
100. Coenen MJ, Trynka G, Heskamp S, et al. Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet 2009;18:4195-4203.
101. Hinks A, Martin P, Flynn E, et al. Investigation of type 1 diabetes and coeliac disease susceptibility loci for association with juvenile idiopathic arthritis. Ann Rheum Dis 2010;69:2169-2172.
102. Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008;359:2767-2777.
103. Zhernakova A, Stahl EA, Trynka G, et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 2011;7:e1002004.
104. Parkes M, Cortes A, van Heel DA, Brown MA. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet 2013;14:661-673.
105. Kilpinen H, Barrett JC. How next-generation sequencing is transforming complex disease genetics. Trends Genet 2013;29:23-30.
106. Radford-Smith G, Doecke JD, Lees CW, et al. Clinical and Molecular Characterization of Medically Refractory Acute, Severe Colitis: Preliminary Results From the International Inflammatory Bowel Disease Genetics Consortium (IIBDGC) Immunochip Study. Gastroenterology 2013;144:S-470.